Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Gossamer Bio
(NASDAQ:GOSS)
Intraday
$0.7085
0.0002
[0.03%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$0.7085
0.0002
[0.03%]
Last update: 9:10AM
Get Real Time Here
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Gossamer Bio Stock (NASDAQ:GOSS)
Gossamer Bio Stock (NASDAQ: GOSS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, April 05, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
-
Apr 5, 2024, 4:31PM
Wedbush Assumes Gossamer Bio at Outperform, Announces Price Target of $4
Benzinga Newsdesk
-
Apr 5, 2024, 4:57AM
Wednesday, March 27, 2024
Piper Sandler Maintains Overweight on Gossamer Bio, Maintains $15 Price Target
Benzinga Newsdesk
-
Mar 27, 2024, 12:43PM
Wednesday, March 06, 2024
Goldman Sachs Maintains Buy Rating for Gossamer Bio: Here's What You Need To Know
Benzinga Insights
-
Mar 6, 2024, 12:00PM
Goldman Sachs Maintains Buy on Gossamer Bio, Lowers Price Target to $8
Benzinga Newsdesk
-
Mar 6, 2024, 11:36AM
Wedbush Reiterates Outperform on Gossamer Bio, Maintains $6 Price Target
Benzinga Newsdesk
-
Mar 6, 2024, 11:11AM
HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target
Benzinga Newsdesk
-
Mar 6, 2024, 8:44AM
Tuesday, March 05, 2024
Gossamer Bio Q4 EPS $(0.21), Inline; Cash, Cash Equivalents And Marketable Securities Of $296.4M Is Expected To Provide Cash Runway Into The First Half Of 2026
Benzinga Newsdesk
-
Mar 5, 2024, 7:36AM
Monday, March 04, 2024
On March 4, 2024, Gossamer Bio Received Letter Stating That It Has Regained Compliance With Minimum Bid Price Requirement For Continued Listing On Nasdaq
Benzinga Newsdesk
-
Mar 4, 2024, 4:06PM
Tuesday, February 20, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
Feb 20, 2024, 12:31PM
Monday, January 08, 2024
HC Wainwright & Co. Maintains Buy Rating for Gossamer Bio: Here's What You Need To Know
Benzinga Insights
-
Jan 8, 2024, 12:00PM
HC Wainwright & Co. Maintains Buy on Gossamer Bio, Raises Price Target to $10
Benzinga Newsdesk
-
Jan 8, 2024, 6:27AM
Tuesday, December 19, 2023
Wedbush Reiterates Outperform on Gossamer Bio, Maintains $6 Price Target
Benzinga Newsdesk
-
Dec 19, 2023, 8:39AM
Monday, December 18, 2023
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Dec 18, 2023, 1:05PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Dec 18, 2023, 12:32PM
Monday, December 04, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
-
Dec 4, 2023, 4:31PM
Thursday, November 30, 2023
Gossamer Bio Director Awarded $165K Worth of Stock Options
Benzinga Insights
-
Nov 30, 2023, 10:00AM
Thursday, November 23, 2023
Gossamer Bio Chief Medical Officer Awarded $121K Worth of Stock Options
Benzinga Insights
-
Nov 23, 2023, 10:01AM
EVP at Gossamer Bio Acquires Company Stock Options Worth 125,000 Shares
Benzinga Insights
-
Nov 23, 2023, 10:01AM
President & CEO at Gossamer Bio Acquires Company Stock Options Worth 437,500 Shares
Benzinga Insights
-
Nov 23, 2023, 10:01AM
Wednesday, November 15, 2023
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Nov 15, 2023, 12:31PM
Gossamer Bio And 2 Other Stocks Under $1 Insiders Are Buying
Lisa Levin
-
Nov 15, 2023, 9:31AM
Friday, November 10, 2023
Wedbush Maintains Outperform on Gossamer Bio, Raises Price Target to $6
Benzinga Newsdesk
-
Nov 10, 2023, 8:30AM
Thursday, November 09, 2023
Recap: Gossamer Bio Q3 Earnings
Benzinga Insights
-
Nov 9, 2023, 7:45AM
Friday, October 20, 2023
On October 19, Gossamer Bio Inc Got Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Benzinga Newsdesk
-
Oct 20, 2023, 4:05PM
Thursday, October 05, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Oct 5, 2023, 1:22PM
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 3, 2023, 2:37PM
Tuesday, September 26, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 26, 2023, 12:04PM
Thursday, September 21, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 21, 2023, 12:08PM
Friday, September 15, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Sep 15, 2023, 11:52AM
Thursday, September 07, 2023
Gossamer Bio Announced Presentation Of Results Of TORREY FRI Sub-Study At The European Respiratory Society International Congress 2023
Benzinga Newsdesk
-
Sep 7, 2023, 7:46AM
Friday, August 11, 2023
Analyst Expectations for Gossamer Bio's Future
Benzinga Insights
-
Aug 11, 2023, 2:00PM
Wedbush Reiterates Outperform on Gossamer Bio, Maintains $5 Price Target
Benzinga Newsdesk
-
Aug 11, 2023, 10:40AM
Thursday, August 10, 2023
HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $5 Price Target
Benzinga Newsdesk
-
Aug 10, 2023, 6:30AM
Tuesday, August 08, 2023
Gossamer Bio Q2 EPS $(0.45) Beats $(0.50) Estimate
Benzinga Newsdesk
-
Aug 8, 2023, 5:06PM
Wednesday, July 26, 2023
Analyst Ratings for Gossamer Bio
Benzinga Insights
-
Jul 26, 2023, 9:00AM
Wedbush Maintains Outperform on Gossamer Bio, Lowers Price Target to $5
Benzinga Newsdesk
-
Jul 26, 2023, 8:38AM
HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $5 Price Target
Benzinga Newsdesk
-
Jul 26, 2023, 6:10AM
Friday, July 21, 2023
Wedbush Reiterates Outperform on Gossamer Bio, Maintains $7 Price Target
Benzinga Newsdesk
-
Jul 21, 2023, 8:27AM
Thursday, July 20, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Jul 20, 2023, 1:30PM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Jul 20, 2023, 9:06AM
Gossamer Bio shares are trading lower after the company announced a private placement financing of $212 million.
Benzinga Newsdesk
-
Jul 20, 2023, 8:54AM
Gossamer Bio Announced A Private Placement Of Approximately $212M, Issuing 129.8M Shares And Accompanying Warrants To Purchase Up To 32.5M Shares At $1.63125 (Or A Combined Price Of $1.85125 For Participating Officers And Directors)
Benzinga Newsdesk
-
Jul 20, 2023, 8:00AM
Wednesday, June 14, 2023
Why MIND Technology Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
-
Jun 14, 2023, 1:12PM
Thursday, May 11, 2023
HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $5 Price Target
Benzinga Newsdesk
-
May 11, 2023, 6:19AM
Tuesday, April 18, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Apr 18, 2023, 1:15PM
Thursday, April 06, 2023
Skillz And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
Lisa Levin
-
Apr 6, 2023, 8:51AM
Tuesday, April 04, 2023
After Pausing Recruitment, Gossamer Bio Terminates All Studies With CNS Lymphoma Candidate
Vandana Singh
-
Apr 4, 2023, 10:38AM
Monday, April 03, 2023
Gossamer Bio Says FDA Placed Partial Clinical Hold On All Trials Of GB5121 In Response To Serious Adverse Events Observed In Phase 1b/2 STAR-CNS Study
Michael Horton
-
Apr 3, 2023, 4:04PM
Tuesday, March 21, 2023
Barclays Maintains Equal-Weight on Gossamer Bio, Lowers Price Target to $1.5
Benzinga Newsdesk
-
Mar 21, 2023, 5:43AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch